Delivery Order SPE2DX22D0010-SPE2D826FCR00
- Not listed
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $166,128.90 by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026. This firm fixed-price delivery order, which carries an ultimate completion date of January 8, 2026, represents a child contract under the parent entity Cencora, Inc. (doing business as Amerisourcebergen). The award was made through competitive procurement with...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $128,180.25 on January 15, 2026, by the Defense Logistics Agency Medical Supply Chain. The contract utilizes firm fixed-price pricing with an ultimate completion date of January 16, 2026, and was competitively awarded without any set-aside designation. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,175.46 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026. This firm fixed-price delivery order, which will be completed by January 13, 2026, represents a child contract under the parent entity Cencora, Inc. (doing business as Amerisourcebergen). The award was made through full and open competition with no set-aside...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $40,566.20 by the Defense Logistics Agency's Medical Supply Chain on January 13, 2026. This firm fixed-price delivery order, which concludes on January 14, 2026, represents a competitively awarded contract with no set-aside designation. The award leverages Amerisourcebergen's established relationship with the federal government as a critical...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $110,752.60 by the Defense Logistics Agency's Medical Supply Chain on January 14, 2026. This firm fixed-price delivery order, which carries an ultimate completion date of January 15, 2026, was competitively awarded with no set-aside designation. The award is issued as a child contract under the parent organization Cencora, Inc. (doing business as...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $275,058.03 on April 23, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on April 24, 2025, and carries no set-aside designation. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $435,766.30 by the Defense Logistics Agency's Medical Supply Chain on January 15, 2026. This competitive, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of January 16, 2026. The award leverages Amerisourcebergen's extensive capabilities as a critical federal medical supplier, serving military...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,251.32 by the Defense Logistics Agency's Medical Supply Chain on September 19, 2025. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by September 22, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $64,044.00 by the Defense Logistics Agency (DLA) Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract and is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $49,815.06 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, which carries an ultimate completion date of January 20, 2026, represents a child contract under the parent organization Cencora, Inc. (doing business as AmerisourceBergen). The award was made on a competitive, non-set-aside basis and...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCR00Delivery Order
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $54,536.55 on January 22, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of January 23, 2026, was competitively awarded with no set-aside designation. The award is structured as a child contract under Cencora, Inc. (Amerisourcebergen's parent company), leveraging the company's extensive pharmaceutical distribution capabilities to support federal medical procurement requirements. This delivery order operates under Amerisourcebergen's broader Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. This comprehensive IDC enables the company to supply a wide range of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities—to support military healthcare programs globally. The delivery order represents a standard execution of the company's federal medical supply mission, demonstrating its continued role as a critical vendor for Defense Department healthcare systems and military treatment facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $54.5k | 1/21/26 |